These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22041696)

  • 21. Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins.
    Mitchell LA; Koval M
    Toxins (Basel); 2010 Jul; 2(7):1595-611. PubMed ID: 22069652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis.
    Takahashi A; Komiya E; Kakutani H; Yoshida T; Fujii M; Horiguchi Y; Mizuguchi H; Tsutsumi Y; Tsunoda S; Koizumi N; Isoda K; Yagi K; Watanabe Y; Kondoh M
    Biochem Pharmacol; 2008 Apr; 75(8):1639-48. PubMed ID: 18342294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Modified
    Beier LS; Rossa J; Woodhouse S; Bergmann S; Kramer HB; Protze J; Eichner M; Piontek A; Vidal-Y-Sy S; Brandner JM; Krause G; Zitzmann N; Piontek J
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay.
    Watari A; Kodaka M; Matsuhisa K; Sakamoto Y; Hisaie K; Kawashita N; Takagi T; Yamagishi Y; Suzuki H; Tsujino H; Yagi K; Kondoh M
    Sci Rep; 2017 Nov; 7(1):14514. PubMed ID: 29109448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Claudin as a target for drug development.
    Takahashi A; Kondoh M; Suzuki H; Yagi K
    Curr Med Chem; 2011; 18(12):1861-5. PubMed ID: 21466467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for disruption of claudin assembly in tight junctions by an enterotoxin.
    Shinoda T; Shinya N; Ito K; Ohsawa N; Terada T; Hirata K; Kawano Y; Yamamoto M; Kimura-Someya T; Yokoyama S; Shirouzu M
    Sci Rep; 2016 Sep; 6():33632. PubMed ID: 27647526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide.
    Uchida H; Kondoh M; Hanada T; Takahashi A; Hamakubo T; Yagi K
    Biochem Pharmacol; 2010 May; 79(10):1437-44. PubMed ID: 20096266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin.
    Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y
    J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
    Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
    Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
    Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
    Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of Claudin-Made Tight Junction Barriers by
    Ogbu CP; Roy S; Vecchio AJ
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Claudin-binder C-CPE mutants enhance permeability of insulin across human nasal epithelial cells.
    Kojima T; Kondoh M; Keira T; Takano KI; Kakuki T; Kaneko Y; Miyata R; Nomura K; Obata K; Kohno T; Konno T; Sawada N; Himi T
    Drug Deliv; 2016 Oct; 23(8):2703-2710. PubMed ID: 26036653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin.
    Harada M; Kondoh M; Ebihara C; Takahashi A; Komiya E; Fujii M; Mizuguchi H; Tsunoda S; Horiguchi Y; Yagi K; Watanabe Y
    Biochem Pharmacol; 2007 Jan; 73(2):206-14. PubMed ID: 17097620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proof of concept for claudin-targeted drug development.
    Suzuki H; Kondoh M; Takahashi A; Yagi K
    Ann N Y Acad Sci; 2012 Jul; 1258():65-70. PubMed ID: 22731717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
    Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
    Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions.
    Rüffer C; Gerke V
    Eur J Cell Biol; 2004 May; 83(4):135-44. PubMed ID: 15260435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functions of claudin tight junction proteins and their complex interactions in various physiological systems.
    Elkouby-Naor L; Ben-Yosef T
    Int Rev Cell Mol Biol; 2010; 279():1-32. PubMed ID: 20797675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation.
    Garcia-Hernandez V; Quiros M; Nusrat A
    Ann N Y Acad Sci; 2017 Jun; 1397(1):66-79. PubMed ID: 28493289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structures of claudins: insights into their intermolecular interactions.
    Suzuki H; Tani K; Fujiyoshi Y
    Ann N Y Acad Sci; 2017 Jun; 1397(1):25-34. PubMed ID: 28605828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conceptual barriers to understanding physical barriers.
    Lingaraju A; Long TM; Wang Y; Austin JR; Turner JR
    Semin Cell Dev Biol; 2015 Jun; 42():13-21. PubMed ID: 26003050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.